Foundations of Substance Use Disorder care II
Purpose: Help clinicians and their teams practicing in primary care clinics and other settings to identify and treat substance use disorders (SUD). This ECHO introduces a systems perspective to providing SUD care and buprenorphine prescribing within primary care clinics
Audience: Clinicians (prescribing MD, DO, NP, PA), nurses, social workers, pharmacists, behavioral health specialists, practice managers, and quality improvement specialists are encouraged to register. Primary care teams are highly encouraged to participate together including prescribers and other care team members.
Sample topics: Health disparities, stigma, and structural factors affecting addiction care; Buprenorphine inductions; comparing protocols; Harm reduction principles applied to buprenorphine prescribing; Wellness in SUD treatment programs; Pregnant patients and SUD
Schedule: 12 sessions. Wednesdays, 12:00 - 1:00 p.m., January 8 - March 19, 2025
Faculty:
Eleasa Sokolski, MD, Assistant Professor of Medicine and Psychiatry, OHSU; Addiction Medicine ECHO Deputy Director
Stacie Andoniadis, BS, Program Manager, Medication for Addiction Treatment, CareOregon
Lydia Bartholow, PMHNP, CARN-PA, FIAAN, Medical Director of Substance Use Disorder Services at Unity Behavioral Health, Associate Professor UCSF SON, Assistant Professor OHSU SOM and SON
Heather Starbird, LPC, Counselor, Mosaic Community Health
